Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melano – news.modernatx.com April 16, 2023
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters – Nature.com April 3, 2023
Natural Immunity Superior to Vaccination Against Infection in Children: Study January 23, 2023January 22, 2023
Research Shows Video Game Players Have Enhanced Brain Activity and Superior Decision-Making Skills July 26, 2022July 25, 2022
Aiming The Gaming & Visual Cloud-Based Segment With a Focus on AI & Superior Performance November 1, 2021October 31, 2021